136.50
+1.50
+(1.11%)
At close: 4:14:33 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
11,334,000.00
10,345,000.00
9,808,000.00
5,963,000.00
4,799,000.00
Investing Cash Flow
-7,876,000.00
-4,064,000.00
-2,960,000.00
-11,058,000.00
-285,000.00
Financing Cash Flow
-3,616,000.00
-6,567,000.00
-6,823,000.00
3,649,000.00
-2,203,000.00
End Cash Position
4,461,000.00
5,637,000.00
5,983,000.00
6,038,000.00
7,546,000.00
Capital Expenditure
-4,577,000.00
-3,778,000.00
-2,571,000.00
-2,200,000.00
-2,606,000.00
Issuance of Capital Stock
-45,000.00
33,000.00
29,000.00
29,000.00
30,000.00
Issuance of Debt
6,492,000.00
3,816,000.00
--
12,929,000.00
2,968,000.00
Repayment of Debt
-4,934,000.00
-4,942,000.00
-1,271,000.00
-4,759,000.00
-1,609,000.00
Free Cash Flow
6,757,000.00
6,567,000.00
7,237,000.00
3,763,000.00
2,193,000.00
12/31/2020 - 12/28/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LLY.DU Eli Lilly and Co
790.90
+0.53%
RHO6.SG Roche Holding AG
37.62
+0.99%
AMG.DE Amgen Inc.
274.70
+1.22%
RHO6.BE Roche Holding AG
37.80
0.00%
LLY.MU Eli Lilly and Co
791.10
+2.42%
RHHBF Roche Holding AG
331.66
0.00%
NOVN.SW Novartis AG
95.58
+1.90%
NOV.DE Novo Nordisk A/S
81.62
+0.25%
NVS Novartis AG
104.72
-0.03%
BIIB Biogen Inc.
143.93
-1.57%